Patient-controlled Versus Anesthesiologist-controlled Propofol-remifentanil in Awake Craniotomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00992940|
Recruitment Status : Withdrawn (Funds needed to carry on the project were not secured.)
First Posted : October 9, 2009
Last Update Posted : January 9, 2013
|Condition or disease||Intervention/treatment||Phase|
|Awake Craniotomy for Brain Tumour Surgery||Procedure: Patient-Controlled Sedation/Analgesia Procedure: Anesthetist-Controlled Sedation/Analgesia||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||A Comparison of Patient-controlled Versus Anesthesiologist-controlled Propofol-remifentanil in Awake Craniotomy for Tumor Surgery|
Experimental: Patient-Controlled Sedation/Analgesia
Patient controls the amount of sedation and analgesia delivered, according to their own requirements.
Procedure: Patient-Controlled Sedation/Analgesia
Patient controls delivery of sedation and analgesia requirements.
Active Comparator: Anesthetist-Controlled Sedation/Analgesia
Patient sedation and analgesia requirements are delivered by the anesthetist.
Procedure: Anesthetist-Controlled Sedation/Analgesia
All sedation and analgesia requirements are determined and delivered by the attending anesthetist.
- To assess the ability of patient-controlled sedation/analgesia remifentanil-propofol to maintain appropriate levels of sedation and analgesia in commensuration with the needs of the surgery at different stages. [ Time Frame: 2 hours, 24 hours ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00992940
|Toronto Western Hospital, University Health Network|
|Toronto, Ontario, Canada, M5T 2S8|
|Principal Investigator:||Pirjo Manninen, MD||University Health Network, Toronto|